Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Apogee Therapeutics Inc (APGE)

Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,533,444
  • Shares Outstanding, K 44,999
  • Annual Sales, $ 0 K
  • Annual Income, $ -83,990 K
  • EBIT $ -144 M
  • EBITDA $ -147 M
  • 60-Month Beta 2.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.04

Options Overview Details

View History
  • Implied Volatility 81.06% ( -1.43%)
  • Historical Volatility 44.06%
  • IV Percentile 88%
  • IV Rank 74.53%
  • IV High 89.74% on 10/15/24
  • IV Low 55.65% on 05/23/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 1,377
  • Open Int (30-Day) 2,308

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.73
  • Number of Estimates 4
  • High Estimate -0.65
  • Low Estimate -0.80
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -43.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.48 +12.16%
on 10/31/24
57.45 -1.44%
on 10/17/24
+2.14 (+3.93%)
since 10/04/24
3-Month
39.15 +44.62%
on 08/12/24
60.82 -6.91%
on 09/23/24
+15.70 (+38.37%)
since 08/05/24
52-Week
14.19 +299.01%
on 11/10/23
72.29 -21.68%
on 03/13/24
+37.54 (+196.75%)
since 11/03/23

Most Recent Stories

More News
Apogee Therapeutics to Participate in Upcoming November Investor Conferences

APGE : 56.62 (+0.57%)
Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases

APGE : 56.62 (+0.57%)
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting

APGE : 56.62 (+0.57%)
2 Russell 2000 Stocks With More Than 29% Upside Potential to Grab Now

Wall Street rates both of these outperforming small-cap stocks a “strong buy," with 29% or more upside expected over the next year.

ACMR : 18.64 (+0.43%)
$SPX : 5,759.32 (+0.82%)
APGE : 56.62 (+0.57%)
5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap...

GOOGL : 169.72 (+0.28%)
AMZN : 196.87 (+0.56%)
AAPL : 223.27 (+0.57%)
META : 567.90 (+1.29%)
MSFT : 412.84 (+1.07%)
NVDA : 138.95 (+2.13%)
TSLA : 252.06 (+3.80%)
MAGS : 48.33 (+1.45%)
$IUXX : 20,177.72 (+1.07%)
VKTX : 67.10 (+6.27%)
SOUN : 5.28 (+3.73%)
APGE : 56.62 (+0.57%)
Technology Stocks Retreat and Drag the Overall Market Lower

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.80%. Stock indexes...

$SPX : 5,759.32 (+0.82%)
SPY : 574.04 (+0.74%)
$DOWI : 42,043.52 (+0.60%)
DIA : 420.60 (+0.61%)
$IUXX : 20,177.72 (+1.07%)
QQQ : 490.55 (+0.93%)
^BTCUSD : 70,040.56 (+4.47%)
ZNZ24 : 109-310 (-0.35%)
ALB : 99.24 (-1.32%)
AAPL : 223.27 (+0.57%)
QRVO : 71.80 (+0.60%)
QCOM : 166.65 (+0.89%)
Equities Slide on Weakness in Technology Stocks

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.56%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.77%. Stock indexes this...

$SPX : 5,759.32 (+0.82%)
SPY : 574.04 (+0.74%)
$DOWI : 42,043.52 (+0.60%)
DIA : 420.60 (+0.61%)
$IUXX : 20,177.72 (+1.07%)
QQQ : 490.55 (+0.93%)
ZNZ24 : 109-310 (-0.35%)
ALB : 99.24 (-1.32%)
AAPL : 223.27 (+0.57%)
AVGO : 172.82 (+2.53%)
MU : 102.68 (+0.93%)
QCOM : 166.65 (+0.89%)
Tech Stock Weakness Weighs on the Overall Market

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.95%. Stock indexes this...

$SPX : 5,759.32 (+0.82%)
SPY : 574.04 (+0.74%)
$DOWI : 42,043.52 (+0.60%)
DIA : 420.60 (+0.61%)
$IUXX : 20,177.72 (+1.07%)
QQQ : 490.55 (+0.93%)
ZNZ24 : 109-310 (-0.35%)
ALB : 99.24 (-1.32%)
AAPL : 223.27 (+0.57%)
AVGO : 172.82 (+2.53%)
MU : 102.68 (+0.93%)
QCOM : 166.65 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) NanoAbs for Psoriasis May Offer Significant Advantages Over Apogee

Psoriasis is a chronic disease in which the immune system becomes overactive, causing skin cells to multiply too quickly. According to the National Psoriasis Foundation, 125 million people worldwide have...

APGE : 56.62 (+0.57%)
SCNI : 3.65 (+2.53%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Advances NanoAb as IL-17 Drug Candidate for Psoriasis

Modern-day medicine has been revolutionized and personalized to cater to more specific disease characteristics. A prime example of this innovation is monoclonal antibodies (“mAbs”) and nanosized antibodies...

APGE : 56.62 (+0.57%)
BVXV : 1.3600 (+3.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 62.73
2nd Resistance Point 59.87
1st Resistance Point 58.08
Last Price 56.62
1st Support Level 53.44
2nd Support Level 50.58
3rd Support Level 48.80

See More

52-Week High 72.29
Last Price 56.62
Fibonacci 61.8% 50.10
Fibonacci 50% 43.24
Fibonacci 38.2% 36.38
52-Week Low 14.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar